QQ客服 官方微博 反馈留言

	Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor
	Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; Cui, Sheng; He, Yuxian
	2018
卷号	293期号:33页码:12703-12718
关键词	human immunodeficiency virus (HIV) HIV-1 host-pathogen interaction AIDS antiviral agent drug resistance gp41 fusion inhibitor sifuvirtide
ISSN号	0021-9258
DOI	10.1074/jbc.RA118.003538
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6357644
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yu, Danwei,Ding, Xiaohui,Liu, Zixuan,et al. Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor[J],2018,293(33):12703-12718.
APA	Yu, Danwei.,Ding, Xiaohui.,Liu, Zixuan.,Wu, Xiyuan.,Zhu, Yuanmei.,...&He, Yuxian.(2018).Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor.,293(33),12703-12718.
MLA	Yu, Danwei,et al."Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor".293.33(2018):12703-12718.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。